Canadian Sec - Delayed Quote CAD

Biosenta Inc. (ZRO.CN)

0.3350 -0.0200 (-5.63%)
At close: April 25 at 10:15 AM EDT
Loading Chart for ZRO.CN
DELL
  • Previous Close 0.3550
  • Open 0.0000
  • Bid 0.3300 x --
  • Ask 0.4950 x --
  • Day's Range 0.0000 - 0.0000
  • 52 Week Range 0.0000 - 0.8900
  • Volume 0
  • Avg. Volume 1,513
  • Market Cap (intraday) 9.922M
  • Beta (5Y Monthly) 0.23
  • PE Ratio (TTM) --
  • EPS (TTM) -0.2500
  • Earnings Date May 27, 2024 - May 31, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Biosenta Inc. develops, manufactures, and sells chemical compounds for household and industrial applications in Canada. The company develops True, an anti-microbial, dual-action disinfectant for destroying viruses, bacteria, germs, molds, mildew, and fungi. It also manufactures and distributes Tri-Filler, an anti-microbial filler to perform filling and bulking functions. The company is based in Toronto, Canada.

www.biosenta.com

--

Full Time Employees

September 30

Fiscal Year Ends

Recent News: ZRO.CN

Performance Overview: ZRO.CN

Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ZRO.CN
52.27%
S&P/TSX Composite index
4.42%

1-Year Return

ZRO.CN
45.65%
S&P/TSX Composite index
5.85%

3-Year Return

ZRO.CN
46.83%
S&P/TSX Composite index
14.57%

5-Year Return

ZRO.CN
378.57%
S&P/TSX Composite index
31.95%

Compare To: ZRO.CN

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ZRO.CN

Valuation Measures

Annual
As of 4/25/2024
  • Market Cap

    9.92M

  • Enterprise Value

    15.52M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    9.81k

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    16.84k

  • Enterprise Value/EBITDA

    -2.48

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -357.11%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    922

  • Net Income Avi to Common (ttm)

    -6.53M

  • Diluted EPS (ttm)

    -0.2500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    144.61k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -163.62k

Company Insights: ZRO.CN

People Also Watch